Replies to post #3487 on Marker Therapeutics Inc (MRKR)

[Bio7mm]

I know it is early and we only have Phase I results, but when I read about the combination of newly discovered epitopes from Keith Knutson and consider they will be combined with our PolyStart with TAP technology, and read the publicly available info comparing our vaccines with those of Galena, I conclude we will make history. I am prone to being overly optimistic, but I believe we will have something more effective than Herceptin.